Updated on 2023/11/30

写真a

 
OHTA Tsuyoshi
 
Title
Lecturer
Date of Birth
1975
Contact information
メールアドレス
Laboratory Phone number
+81-23-628-5393
 
Laboratory Fax number
+81-23-628-5396
 
Departments URL
 

Research Areas

  • Life Science / Obstetrics and gynecology

 

Papers

  • Squamous cell carcinoma arising from a mature cystic teratoma of the ovary: Successful treatment with carboplatin, paclitaxel, and bevacizumab., Gynecologic oncology reports, 34 100632, 2020.11

    Mika Fukase, Tsuyoshi Ohta, Norikazu Watanabe, Yuriko Suzuki, Manabu Seino, Takeshi Sudo, Satoru Nagase

    Multiple Authorship (Including Foreigners)

  • xCT inhibitor sulfasalazine depletes paclitaxel-resistant tumor cells through ferroptosis in uterine serous carcinoma., Oncology letters, 20(3) 2689-2700, 2020.09

    Akiko Sugiyama, Tsuyoshi Ohta, Miyuki Obata, Kanako Takahashi, Manabu Seino, Satoru Nagase

    Multiple Authorship (Including Foreigners)

  • Successful management of cutaneous lymphangitis carcinomatosa arising from cervical cancer with paclitaxel-cisplatin and bevacizumab combination therapy: a case report and review of the literature., Journal of medical case reports, 13(1) 328, 2019.11

    Nakamura F, Seino M, Suzuki Y, Sakaki H, Sudo T, Ohta T, Tsutsumi S, Nagase S

    Multiple Authorship (Including Foreigners)

  • Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patients report for 2015 and annual treatment report for 2010, Journal of Obstetrics and Gynaecology Research, 45(2) 289-298, 2019

    Nagase S, Ohta T, Takahashi F, Enomoto T

    Multiple Authorship (Including Foreigners)

  • Metabolomic analysis of uterine serous carcinoma with acquired resistance to paclitaxel., Oncotarget, 9(62) 31985-31998, 2018.08

    Seino M, Ohta T, Sugiyama A, Sakaki H, Sudo T, Tsutsumi S, Shigeta S, Tokunaga H, Toyoshima M, Yaegashi N, Nagase S

    Multiple Authorship (Including Foreigners)

  • Tumor lysis syndrome associated with docetaxel and carboplatin in a case with recurrent endometrial cancer, Gynecologic Oncology Reports, 24 21-23, 2018.05

    Tomomichi Ito, Tsuyoshi Ohta, Megumi Narumi, Hirotsugu Sakaki, Manabu Seino, Takeshi Sudo, Satoru Nagase

    Multiple Authorship (Including Foreigners)

  • Activation of estrogen receptor α by estradiol and cisplatin induces platinum-resistance in ovarian cancer cells., Cancer biology & therapy, 18(9) 730-739, 2017.09

    Matsumura S, Ohta T, Yamanouchi K, Liu Z, Sudo T, Kojimahara T, Seino M, Narumi M, Tsutsumi S, Takahashi T, Takahashi K, Kurachi H, Nagase S

    Multiple Authorship (Including Foreigners)

  • Three-dimensional computed tomography of pelvic masses in Mayer-Rokitansky-Küster-Hauser syndrome., Obstetrics and gynecology, 125(2) 393-396, 2015.02

    Hasegawa A, Igarashi H, Ohta T, Kurachi H, Takahashi K

    Multiple Authorship (Including Foreigners)

  • The Wilms' Tumor Gene WT1 - 17AA/- KTS Splice Variant Increases Tumorigenic Activity Through Up-Regulation of Vascular Endothelial Growth Factor in an In Vivo Ovarian Cancer Model., Translational oncology, 7(5) 580-589, 2014.10

    Yamanouchi K, Ohta T, Liu Z, Oji Y, Sugiyama H, Shridhar V, Matsumura S, Takahashi T, Takahashi K, Kurachi H

    Multiple Authorship (Including Foreigners)

  • Non-Sex Cord-Stromal Ovarian Tumors Frequently Produce and Secrete Estrogen in Postmenopausal Women: Impact on Bone Metabolism and Abnormal Endometrial Histology, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 98(7) 2775-2782, 2013.07

    Sohei Matsumura, Tsuyoshi Ohta, Toshifumi Takahashi, Takeshi Yamazaki, Kazuhiro Takahashi, Hirohisa Kurachi

    Multiple Authorship (Including Foreigners)

  • Gefitinib (ZD1839) increases the efficacy of cisplatin in ovarian cancer cells, CANCER BIOLOGY & THERAPY, 13(6) 408-416, 2012.04

    Tsuyoshi Ohta, Masahide Ohmichi, Tae Shibuya, Toshifumi Takahashi, Seiji Tsutsumi, Kazuhiro Takahashi, Hirohisa Kurachi

    Multiple Authorship (Including Foreigners)

  • Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1α in human ovarian cancer cells., Cancer biology & therapy, 13(1) 25-33, 2012.01

    Ohta T, Takahashi T, Shibuya T, Amita M, Henmi N, Takahashi K, Kurachi H

    Multiple Authorship (Including Foreigners)

  • The Akt and ERK Activation by Platinum-based Chemotherapy in Ovarian Cancer is Associated with Favorable Patient Outcome, ANTICANCER RESEARCH, 29(11) 4639-4647, 2009.11

    Tsuyoshi Ohta, Masanori Isobe, Toshifumi Takahashi, Maki Saitoh-Sekiguchi, Teiichi Motoyama, Hirohisa Kurachi

    Multiple Authorship (Including Foreigners)

  • Fasudil inhibits vascular endothelial growth factor - induced angiogenesis in vitro and in vivo, MOLECULAR CANCER THERAPEUTICS, 6(5) 1517-1525, 2007.05

    Limei Yin, Ken-ichirou Morishige, Toshifumi Takahashi, Kae Hashimoto, Seiji Ogata, Seiji Tsutsumi, Keiko Takata, Tsuyoshi Ohta, Jun Kawagoe, Kazuhiro Takahashi, Hirohisa Kurachi

    Single Author

  • Torsion of a nongravid uterus with a large ovarian cyst: Usefulness of contrast MR image, GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 63(3) 163-165, 2007

    Hiroki Matsumoto, Tsuyoshi Ohta, Kenji Nakahara, Takanobu Kojimahara, Hirohisa Kurachi

    Single Author

  • Inhibition of phosphatidylinositol 3-kinase increases efficacy of cisplatin in in vivo ovarian cancer models, ENDOCRINOLOGY, 147(4) 1761-1769, 2006.04

    T Ohta, M Ohmichi, T Hayasaka, S Mabuchi, M Saitoh, J Kawagoe, K Takahashi, H Igarashi, BT Du, M Doshida, IG Mirei, T Motoyama, K Tasaka, H Kurachi

    Single Author

  • Characteristic features of ovarian borderline tumors with invasive implant, Archives of Gynecology and Obstetrics, 272(4) 278-282, 2005.12

    Tsuyoshi Ohta, Masahide Ohmichi, Tadashi Hayasaka, Maki Saitoh, Takanobu Kojimahara, Jun Kawagoe, Kenji Nakahara, Teiichi Motoyama, Hirohisa Kurachi

    Single Author

display all >>

Grant-in-Aid for Scientific Research

  • Grant-in-Aid for Scientific Research(C),2021.04 - 2023.03

  • Grant-in-Aid for Scientific Research(C),2021.04 - 2023.03

  • Grant-in-Aid for Scientific Research(C),2021.04 - 2023.03

  • Grant-in-Aid for Scientific Research(C),2018.04 - 2021.03

  • Grant-in-Aid for Scientific Research(C),2018.04 - 2019.03

  • Grant-in-Aid for Scientific Research(C),2017.04 - 2020.03

display all >>